SENIOR LEADERSHIP
SENIOR LEADERSHIP
批准号:
8089515
负责人:
BRIAN LEYLAND-JONES
金额:
$18.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
American Cancer SocietyAntineoplastic AgentsAppointmentBiological MarkersBreast Cancer TreatmentBudgetsCanadaCancer CenterCancer Center Support GrantCenters for Disease Control and Prevention (U.S.)ClinicalClinical TrialsClinical Trials Cooperative GroupCollaborationsCommitCommittee MembershipCommunitiesComprehensive Cancer CenterDevelopmentDiseaseDoctor of PhilosophyEvaluationFacultyFoundationsGoalsHeadHealth SciencesIn VitroIndividualInstitutesInstitutionInvestigational DrugsLeadLeadershipMalignant NeoplasmsMedical OncologistMedicineMolecularNational Cancer InstitutePatient advocacyPharmacogeneticsPharmacologic SubstancePharmacologyPhasePhase III Clinical TrialsPhysiciansPopulation SciencesPositioning AttributePrincipal InvestigatorProtocols documentationPublic Health NursesPublic Health NursingQualifyingRecruitment ActivityResearchResourcesRoleScientistScreening procedureStagingStrategic PlanningStructureTechnologyTimeUniversitiesWorkadvocacy organizationsauthoritycancer therapychemotherapycollegeexperiencemedical schoolsmeetingsmultidisciplinarynoveloncologyoperationprofessorprogramstherapy development
中文摘要
7.1 Winship癌症研究所的高层领导
英文摘要
7.1 Senior Leadership of the Winship Cancer Institute
Director of the Winship Cancer Institute and Associate Vice-President for the
Woodruff Health Sciences Center: Brian Leyland-Jones, MD, PhD
Dr. Leyland-Jones was appointed Director of Emory's Winship Cancer Institute (WCI) and
Associate Director of the Woodruff Health Sciences Center (WHSC) effective January 1, 2007.
He is eminently well-qualified to serve as WCI Director. A Medical Oncologist who specializes in
breast cancer treatment, with a Ph.D. in Molecular Pharmacology, Dr. Leyland-Jones is a
translational physician-scientist who is internationally recognized for his work in individualized
cancer therapies and development of novel clinical trials. Prior to his appointment, Dr. Leyland-
Jones was the Minda de Gunzberg Chair in Oncology and Professor of Medicine at McGill
University in Montreal, Canada. From 1990 to 2000, he served as founding Chair of Oncology
and Director of the McGill University Comprehensive Cancer Centre. From 1983-89 he was
Head, Developmental Chemotherapy Section in the Investigational Drug Branch, Division of
Cancer Treatment, at the National Cancer Institute.
Dr. Leyland-Jones' capacity to lead the efforts at the Winship Cancer Institute is
demonstrated through his prior senior positions and experiences as a premier translational
scientist. During his tenure as Director of the McGill Comprehensive Cancer Centre, Dr.
Leyland-Jones led development of a clinical trials operation that integrated research with five
clinical trial cooperative groups and more than 40 pharmaceutical companies. Under Dr.
Leyland-Jones' direction, cancer-related clinical trials at McGill included more than 100
protocols at any one time and were structured through nine multidisciplinary disease sections
throughout the Cancer Centre. During his time with the NCI, he was responsible for the overall
development of approximately 70 anti-cancer compounds in various stages of transition from in
vitro screening to Phase III clinical trials. His expertise in pharmacogenetics in oncology clinical
trials and biomarker endpoints in Phase l/ll anti-cancer agents underscores his superb
background to lead the WCI and its scientific programs and shared core resources in this
pursuit of NCI designation as a cancer center.
In his role as Director of the Winship Cancer Institute, Dr. Leyland-Jones provides overall
leadership of the WCI, its scientific programs, its shared core resources, its organization, and its
administration. Dr. Leyland-Jones represents the WCI on strategic planning and leadership
committees within the Woodruff Health Sciences Center and on the School of Medicine's
Council of Chairs. The Authority of the Director is described in considerable detail in the
previous section. Dr. Leyland-Jones controls the space, facilities, allocation of fundraising,
budget, and other resources of the Winship Cancer Institute. Jointly with individual Department
Chairs, he has the ability to recruit new faculty to Emory University, and with the Membership
Committee he oversees membership in the WCI. As Director of a matrix Center, Dr. Leyland-
Jones interacts closely with other Deans and Department Chairs in the Schools of Medicine,
Nursing, and Public Health in the Woodruff Health Sciences Center and in Emory College. He
also represents the WCI in collaborations with our community partners, including the American
Cancer Society, CDC, Georgia Cancer Coalition, Georgia Research Alliance, Georgia Institute
for Technology, Morehouse School of Medicine, GA-CORE, and other institutions throughout
Georgia. Dr. Leyland-Jones provides the interface with the National Cancer Institute, with the
national and local media, and with patient advocacy organizations and foundations.
Dr. Leyland-Jones is committed full-time to his role as WCI Director and as Principal
Investigator for the CCSG, but only 25% of his effort is supported by the CCSG budget. He will
provide senior leadership, oversight, strategic planning, and on-going evaluation of progress
towards meeting established goals and objectives during the course of the project period.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Towards identification of prognostic gene sets in breast cancer: The E2197 Trial
-
批准号:8111749
-
项目类别:
-
资助金额:$16.29万
-
财政年份:2010
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
Towards identification of prognostic gene sets in breast cancer: The E2197 Trial
-
批准号:7878367
-
项目类别:
-
资助金额:$21.11万
-
财政年份:2010
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
CLINICAL TRIALS - PROTOCOL REVIEW MONITORING SYSTEM
-
批准号:7944911
-
项目类别:
-
资助金额:$7.98万
-
财政年份:2009
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
DATA SAFETY MONITORING PLAN
-
批准号:7944930
-
项目类别:
-
资助金额:$1.48万
-
财政年份:2009
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
PROGRAM PLANNING & EVALUATION
-
批准号:7944862
-
项目类别:
-
资助金额:$5.43万
-
财政年份:2009
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
DEVELOPMENTAL FUNDS
-
批准号:7944866
-
项目类别:
-
资助金额:$13.41万
-
财政年份:2009
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
CLINICAL TRIALS- PROTOCOL SPECIFIC
-
批准号:7944927
-
项目类别:
-
资助金额:$1.05万
-
财政年份:2009
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
Prognostic and predictive gene sets in HER2-positive breast cancer:The HERA Trial
-
批准号:7643722
-
项目类别:
-
资助金额:$21.41万
-
财政年份:2009
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
SENIOR LEADERSHIP
-
批准号:7944855
-
项目类别:
-
资助金额:$16.83万
-
财政年份:2009
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
CANCER AND LEUKEMIA GROUP B
-
批准号:3557184
-
项目类别:
-
资助金额:$6.01万
-
财政年份:1982
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
CLINICAL TRIALS- PROTOCOL SPECIFIC
-
批准号:8089529
-
项目类别:
-
资助金额:$1.15万
-
财政年份:--
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
DEVELOPMENTAL FUNDS
-
批准号:8089518
-
项目类别:
-
资助金额:$15.57万
-
财政年份:--
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
PROGRAM PLANNING & EVALUATION
-
批准号:8089517
-
项目类别:
-
资助金额:$5.92万
-
财政年份:--
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
CLINICAL TRIALS - PROTOCOL REVIEW MONITORING SYSTEM
-
批准号:8089528
-
项目类别:
-
资助金额:$8.71万
-
财政年份:--
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
DATA SAFETY MONITORING PLAN
-
批准号:8089530
-
项目类别:
-
资助金额:$1.61万
-
财政年份:--
-
负责人:BRIAN LEYLAND-JONES
-
依托单位:
海外基金